Industry Research Reports

Home > Reports > Service & Software > Drug Modeling Softwares- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Drug Modeling Softwares- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-02-20

Pages: 85 Pages

Report ld: 4021913

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Drug Modeling Softwares was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drug Modeling Softwares, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug Modeling Softwares by region & country, by Type, and by Application.

The Drug Modeling Softwares market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Modeling Softwares.

MARKET SEGMENTATION

By Company

JSR Corporation(Crown Bioscience)
Chemical Computing Group ULC
Nimbus Therapeutics
Schrodinger, Inc
Genedata AG
Biognos AB
Compugen Ltd
Dassault Systemes
Acellera
Instem(Leadscope)

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Database
Software
Others

Segment by Application

Drug Discovery and Development
Computational Physiological Medicine
Disease Modelling
Medical Imaging
Predictive Analysis of Drug Targets
Simulation Software
Cellular Simulation
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Drug Modeling Softwares company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Drug Modeling Softwares in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Drug Modeling Softwares in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Drug Modeling Softwares Product Introduction

1.2 Global Drug Modeling Softwares Market Size Forecast (2020-2031)

1.3 Drug Modeling Softwares Market Trends & Drivers

1.3.1 Drug Modeling Softwares Industry Trends

1.3.2 Drug Modeling Softwares Market Drivers & Opportunity

1.3.3 Drug Modeling Softwares Market Challenges

1.3.4 Drug Modeling Softwares Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Drug Modeling Softwares Players Revenue Ranking (2024)

2.2 Global Drug Modeling Softwares Revenue by Company (2020-2025)

2.3 Key Companies Drug Modeling Softwares Manufacturing Base Distribution and Headquarters

2.4 Key Companies Drug Modeling Softwares Product Offered

2.5 Key Companies Time to Begin Mass Production of Drug Modeling Softwares

2.6 Drug Modeling Softwares Market Competitive Analysis

2.6.1 Drug Modeling Softwares Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Drug Modeling Softwares Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Modeling Softwares as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Database

3.1.2 Software

3.1.3 Others

3.2 Global Drug Modeling Softwares Sales Value by Type

3.2.1 Global Drug Modeling Softwares Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Drug Modeling Softwares Sales Value, by Type (2020-2031)

3.2.3 Global Drug Modeling Softwares Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Drug Discovery and Development

4.1.2 Computational Physiological Medicine

4.1.3 Disease Modelling

4.1.4 Medical Imaging

4.1.5 Predictive Analysis of Drug Targets

4.1.6 Simulation Software

4.1.7 Cellular Simulation

4.1.8 Others

4.2 Global Drug Modeling Softwares Sales Value by Application

4.2.1 Global Drug Modeling Softwares Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Drug Modeling Softwares Sales Value, by Application (2020-2031)

4.2.3 Global Drug Modeling Softwares Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Drug Modeling Softwares Sales Value by Region

5.1.1 Global Drug Modeling Softwares Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Drug Modeling Softwares Sales Value by Region (2020-2025)

5.1.3 Global Drug Modeling Softwares Sales Value by Region (2026-2031)

5.1.4 Global Drug Modeling Softwares Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Drug Modeling Softwares Sales Value, 2020-2031

5.2.2 North America Drug Modeling Softwares Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Drug Modeling Softwares Sales Value, 2020-2031

5.3.2 Europe Drug Modeling Softwares Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Drug Modeling Softwares Sales Value, 2020-2031

5.4.2 Asia Pacific Drug Modeling Softwares Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Drug Modeling Softwares Sales Value, 2020-2031

5.5.2 South America Drug Modeling Softwares Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Drug Modeling Softwares Sales Value, 2020-2031

5.6.2 Middle East & Africa Drug Modeling Softwares Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Drug Modeling Softwares Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Drug Modeling Softwares Sales Value, 2020-2031

6.3 United States

6.3.1 United States Drug Modeling Softwares Sales Value, 2020-2031

6.3.2 United States Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Drug Modeling Softwares Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Drug Modeling Softwares Sales Value, 2020-2031

6.4.2 Europe Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Drug Modeling Softwares Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Drug Modeling Softwares Sales Value, 2020-2031

6.5.2 China Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

6.5.3 China Drug Modeling Softwares Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Drug Modeling Softwares Sales Value, 2020-2031

6.6.2 Japan Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Drug Modeling Softwares Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Drug Modeling Softwares Sales Value, 2020-2031

6.7.2 South Korea Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Drug Modeling Softwares Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Drug Modeling Softwares Sales Value, 2020-2031

6.8.2 Southeast Asia Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Drug Modeling Softwares Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Drug Modeling Softwares Sales Value, 2020-2031

6.9.2 India Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

6.9.3 India Drug Modeling Softwares Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 JSR Corporation(Crown Bioscience)

7.1.1 JSR Corporation(Crown Bioscience) Profile

7.1.2 JSR Corporation(Crown Bioscience) Main Business

7.1.3 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Products, Services and Solutions

7.1.4 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Revenue (US$ Million) & (2020-2025)

7.1.5 JSR Corporation(Crown Bioscience) Recent Developments

7.2 Chemical Computing Group ULC

7.2.1 Chemical Computing Group ULC Profile

7.2.2 Chemical Computing Group ULC Main Business

7.2.3 Chemical Computing Group ULC Drug Modeling Softwares Products, Services and Solutions

7.2.4 Chemical Computing Group ULC Drug Modeling Softwares Revenue (US$ Million) & (2020-2025)

7.2.5 Chemical Computing Group ULC Recent Developments

7.3 Nimbus Therapeutics

7.3.1 Nimbus Therapeutics Profile

7.3.2 Nimbus Therapeutics Main Business

7.3.3 Nimbus Therapeutics Drug Modeling Softwares Products, Services and Solutions

7.3.4 Nimbus Therapeutics Drug Modeling Softwares Revenue (US$ Million) & (2020-2025)

7.3.5 Nimbus Therapeutics Recent Developments

7.4 Schrodinger, Inc

7.4.1 Schrodinger, Inc Profile

7.4.2 Schrodinger, Inc Main Business

7.4.3 Schrodinger, Inc Drug Modeling Softwares Products, Services and Solutions

7.4.4 Schrodinger, Inc Drug Modeling Softwares Revenue (US$ Million) & (2020-2025)

7.4.5 Schrodinger, Inc Recent Developments

7.5 Genedata AG

7.5.1 Genedata AG Profile

7.5.2 Genedata AG Main Business

7.5.3 Genedata AG Drug Modeling Softwares Products, Services and Solutions

7.5.4 Genedata AG Drug Modeling Softwares Revenue (US$ Million) & (2020-2025)

7.5.5 Genedata AG Recent Developments

7.6 Biognos AB

7.6.1 Biognos AB Profile

7.6.2 Biognos AB Main Business

7.6.3 Biognos AB Drug Modeling Softwares Products, Services and Solutions

7.6.4 Biognos AB Drug Modeling Softwares Revenue (US$ Million) & (2020-2025)

7.6.5 Biognos AB Recent Developments

7.7 Compugen Ltd

7.7.1 Compugen Ltd Profile

7.7.2 Compugen Ltd Main Business

7.7.3 Compugen Ltd Drug Modeling Softwares Products, Services and Solutions

7.7.4 Compugen Ltd Drug Modeling Softwares Revenue (US$ Million) & (2020-2025)

7.7.5 Compugen Ltd Recent Developments

7.8 Dassault Systemes

7.8.1 Dassault Systemes Profile

7.8.2 Dassault Systemes Main Business

7.8.3 Dassault Systemes Drug Modeling Softwares Products, Services and Solutions

7.8.4 Dassault Systemes Drug Modeling Softwares Revenue (US$ Million) & (2020-2025)

7.8.5 Dassault Systemes Recent Developments

7.9 Acellera

7.9.1 Acellera Profile

7.9.2 Acellera Main Business

7.9.3 Acellera Drug Modeling Softwares Products, Services and Solutions

7.9.4 Acellera Drug Modeling Softwares Revenue (US$ Million) & (2020-2025)

7.9.5 Acellera Recent Developments

7.10 Instem(Leadscope)

7.10.1 Instem(Leadscope) Profile

7.10.2 Instem(Leadscope) Main Business

7.10.3 Instem(Leadscope) Drug Modeling Softwares Products, Services and Solutions

7.10.4 Instem(Leadscope) Drug Modeling Softwares Revenue (US$ Million) & (2020-2025)

7.10.5 Instem(Leadscope) Recent Developments

8 Industry Chain Analysis

8.1 Drug Modeling Softwares Industrial Chain

8.2 Drug Modeling Softwares Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Drug Modeling Softwares Sales Model

8.5.2 Sales Channel

8.5.3 Drug Modeling Softwares Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Drug Modeling Softwares Market Trends

Table 2. Drug Modeling Softwares Market Drivers & Opportunity

Table 3. Drug Modeling Softwares Market Challenges

Table 4. Drug Modeling Softwares Market Restraints

Table 5. Global Drug Modeling Softwares Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Drug Modeling Softwares Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Drug Modeling Softwares Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Drug Modeling Softwares Product Type

Table 9. Key Companies Time to Begin Mass Production of Drug Modeling Softwares

Table 10. Global Drug Modeling Softwares Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Modeling Softwares as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Drug Modeling Softwares Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Drug Modeling Softwares Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Drug Modeling Softwares Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Drug Modeling Softwares Sales Market Share in Value by Type (2020-2025)

Table 17. Global Drug Modeling Softwares Sales Market Share in Value by Type (2026-2031)

Table 18. Global Drug Modeling Softwares Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Drug Modeling Softwares Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Drug Modeling Softwares Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Drug Modeling Softwares Sales Market Share in Value by Application (2020-2025)

Table 22. Global Drug Modeling Softwares Sales Market Share in Value by Application (2026-2031)

Table 23. Global Drug Modeling Softwares Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Drug Modeling Softwares Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Drug Modeling Softwares Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Drug Modeling Softwares Sales Value by Region (2020-2025) & (%)

Table 27. Global Drug Modeling Softwares Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Drug Modeling Softwares Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Drug Modeling Softwares Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Drug Modeling Softwares Sales Value, (2026-2031) & (US$ Million)

Table 31. JSR Corporation(Crown Bioscience) Basic Information List

Table 32. JSR Corporation(Crown Bioscience) Description and Business Overview

Table 33. JSR Corporation(Crown Bioscience) Drug Modeling Softwares Products, Services and Solutions

Table 34. Revenue (US$ Million) in Drug Modeling Softwares Business of JSR Corporation(Crown Bioscience) (2020-2025)

Table 35. JSR Corporation(Crown Bioscience) Recent Developments

Table 36. Chemical Computing Group ULC Basic Information List

Table 37. Chemical Computing Group ULC Description and Business Overview

Table 38. Chemical Computing Group ULC Drug Modeling Softwares Products, Services and Solutions

Table 39. Revenue (US$ Million) in Drug Modeling Softwares Business of Chemical Computing Group ULC (2020-2025)

Table 40. Chemical Computing Group ULC Recent Developments

Table 41. Nimbus Therapeutics Basic Information List

Table 42. Nimbus Therapeutics Description and Business Overview

Table 43. Nimbus Therapeutics Drug Modeling Softwares Products, Services and Solutions

Table 44. Revenue (US$ Million) in Drug Modeling Softwares Business of Nimbus Therapeutics (2020-2025)

Table 45. Nimbus Therapeutics Recent Developments

Table 46. Schrodinger, Inc Basic Information List

Table 47. Schrodinger, Inc Description and Business Overview

Table 48. Schrodinger, Inc Drug Modeling Softwares Products, Services and Solutions

Table 49. Revenue (US$ Million) in Drug Modeling Softwares Business of Schrodinger, Inc (2020-2025)

Table 50. Schrodinger, Inc Recent Developments

Table 51. Genedata AG Basic Information List

Table 52. Genedata AG Description and Business Overview

Table 53. Genedata AG Drug Modeling Softwares Products, Services and Solutions

Table 54. Revenue (US$ Million) in Drug Modeling Softwares Business of Genedata AG (2020-2025)

Table 55. Genedata AG Recent Developments

Table 56. Biognos AB Basic Information List

Table 57. Biognos AB Description and Business Overview

Table 58. Biognos AB Drug Modeling Softwares Products, Services and Solutions

Table 59. Revenue (US$ Million) in Drug Modeling Softwares Business of Biognos AB (2020-2025)

Table 60. Biognos AB Recent Developments

Table 61. Compugen Ltd Basic Information List

Table 62. Compugen Ltd Description and Business Overview

Table 63. Compugen Ltd Drug Modeling Softwares Products, Services and Solutions

Table 64. Revenue (US$ Million) in Drug Modeling Softwares Business of Compugen Ltd (2020-2025)

Table 65. Compugen Ltd Recent Developments

Table 66. Dassault Systemes Basic Information List

Table 67. Dassault Systemes Description and Business Overview

Table 68. Dassault Systemes Drug Modeling Softwares Products, Services and Solutions

Table 69. Revenue (US$ Million) in Drug Modeling Softwares Business of Dassault Systemes (2020-2025)

Table 70. Dassault Systemes Recent Developments

Table 71. Acellera Basic Information List

Table 72. Acellera Description and Business Overview

Table 73. Acellera Drug Modeling Softwares Products, Services and Solutions

Table 74. Revenue (US$ Million) in Drug Modeling Softwares Business of Acellera (2020-2025)

Table 75. Acellera Recent Developments

Table 76. Instem(Leadscope) Basic Information List

Table 77. Instem(Leadscope) Description and Business Overview

Table 78. Instem(Leadscope) Drug Modeling Softwares Products, Services and Solutions

Table 79. Revenue (US$ Million) in Drug Modeling Softwares Business of Instem(Leadscope) (2020-2025)

Table 80. Instem(Leadscope) Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Drug Modeling Softwares Downstream Customers

Table 84. Drug Modeling Softwares Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Drug Modeling Softwares Product Picture

Figure 2. Global Drug Modeling Softwares Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Drug Modeling Softwares Sales Value (2020-2031) & (US$ Million)

Figure 4. Drug Modeling Softwares Report Years Considered

Figure 5. Global Drug Modeling Softwares Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Drug Modeling Softwares Revenue in 2024

Figure 7. Drug Modeling Softwares Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Database Picture

Figure 9. Software Picture

Figure 10. Others Picture

Figure 11. Global Drug Modeling Softwares Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 12. Global Drug Modeling Softwares Sales Value Market Share by Type, 2024 & 2031

Figure 13. Product Picture of Drug Discovery and Development

Figure 14. Product Picture of Computational Physiological Medicine

Figure 15. Product Picture of Disease Modelling

Figure 16. Product Picture of Medical Imaging

Figure 17. Product Picture of Predictive Analysis of Drug Targets

Figure 18. Product Picture of Simulation Software

Figure 19. Product Picture of Cellular Simulation

Figure 20. Product Picture of Others

Figure 21. Global Drug Modeling Softwares Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Drug Modeling Softwares Sales Value Market Share by Application, 2024 & 2031

Figure 23. North America Drug Modeling Softwares Sales Value (2020-2031) & (US$ Million)

Figure 24. North America Drug Modeling Softwares Sales Value by Country (%), 2024 VS 2031

Figure 25. Europe Drug Modeling Softwares Sales Value, (2020-2031) & (US$ Million)

Figure 26. Europe Drug Modeling Softwares Sales Value by Country (%), 2024 VS 2031

Figure 27. Asia Pacific Drug Modeling Softwares Sales Value, (2020-2031) & (US$ Million)

Figure 28. Asia Pacific Drug Modeling Softwares Sales Value by Region (%), 2024 VS 2031

Figure 29. South America Drug Modeling Softwares Sales Value, (2020-2031) & (US$ Million)

Figure 30. South America Drug Modeling Softwares Sales Value by Country (%), 2024 VS 2031

Figure 31. Middle East & Africa Drug Modeling Softwares Sales Value, (2020-2031) & (US$ Million)

Figure 32. Middle East & Africa Drug Modeling Softwares Sales Value by Country (%), 2024 VS 2031

Figure 33. Key Countries/Regions Drug Modeling Softwares Sales Value (%), (2020-2031)

Figure 34. United States Drug Modeling Softwares Sales Value, (2020-2031) & (US$ Million)

Figure 35. United States Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

Figure 36. United States Drug Modeling Softwares Sales Value by Application (%), 2024 VS 2031

Figure 37. Europe Drug Modeling Softwares Sales Value, (2020-2031) & (US$ Million)

Figure 38. Europe Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

Figure 39. Europe Drug Modeling Softwares Sales Value by Application (%), 2024 VS 2031

Figure 40. China Drug Modeling Softwares Sales Value, (2020-2031) & (US$ Million)

Figure 41. China Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

Figure 42. China Drug Modeling Softwares Sales Value by Application (%), 2024 VS 2031

Figure 43. Japan Drug Modeling Softwares Sales Value, (2020-2031) & (US$ Million)

Figure 44. Japan Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

Figure 45. Japan Drug Modeling Softwares Sales Value by Application (%), 2024 VS 2031

Figure 46. South Korea Drug Modeling Softwares Sales Value, (2020-2031) & (US$ Million)

Figure 47. South Korea Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

Figure 48. South Korea Drug Modeling Softwares Sales Value by Application (%), 2024 VS 2031

Figure 49. Southeast Asia Drug Modeling Softwares Sales Value, (2020-2031) & (US$ Million)

Figure 50. Southeast Asia Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

Figure 51. Southeast Asia Drug Modeling Softwares Sales Value by Application (%), 2024 VS 2031

Figure 52. India Drug Modeling Softwares Sales Value, (2020-2031) & (US$ Million)

Figure 53. India Drug Modeling Softwares Sales Value by Type (%), 2024 VS 2031

Figure 54. India Drug Modeling Softwares Sales Value by Application (%), 2024 VS 2031

Figure 55. Drug Modeling Softwares Industrial Chain

Figure 56. Drug Modeling Softwares Manufacturing Cost Structure

Figure 57. Channels of Distribution (Direct Sales, and Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Drug Modeling Softwares market? zhanKai

The top companies in the global Drug Modeling Softwares market are JSR Corporation(Crown Bioscience)、Chemical Computing Group ULC、Nimbus Therapeutics.

Related Reports

Drug Modeling Softwares - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Modeling Softwares was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 107
USD 3950.00
(Single User License)
Global Drug Modeling Softwares Market Research Report 2026
The global Drug Modeling Softwares market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 109
USD 2900.00
(Single User License)
Global Drug Modeling Softwares Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Modeling Softwares market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 130
USD 4900.00
(Single User License)
Global Drug Modeling Softwares Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Drug Modeling Softwares market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 77
USD 4250.00
(Single User License)
Global Drug Modeling Softwares Market Research Report 2025
The global market for Drug Modeling Softwares was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 75
USD 2900.00
(Single User License)
Global Drug Modeling Softwares Market Insights, Forecast to 2030
Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
Published Date: 2024-04-25
Pages: 107
USD 4900.00
(Single User License)
Drug Modeling Softwares - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
Published Date: 2024-02-22
Pages: 104
USD 3950.00
(Single User License)
Global Drug Modeling Softwares Market Research Report 2024
Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
Published Date: 2024-02-06
Pages: 86
USD 2900.00
(Single User License)

Drug Modeling Softwares - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Modeling Softwares was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 107
USD 3950.00 (Single User License)
Global Drug Modeling Softwares Market Research Report 2026
The global Drug Modeling Softwares market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 109
USD 2900.00 (Single User License)
Global Drug Modeling Softwares Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Modeling Softwares market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 130
USD 4900.00 (Single User License)
Global Drug Modeling Softwares Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Drug Modeling Softwares market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 77
USD 4250.00 (Single User License)
Global Drug Modeling Softwares Market Research Report 2025
The global market for Drug Modeling Softwares was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 75
USD 2900.00 (Single User License)
Global Drug Modeling Softwares Market Insights, Forecast to 2030
Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
Published: 2024-04-25
Pages: 107
USD 4900.00 (Single User License)
Drug Modeling Softwares - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
Published: 2024-02-22
Pages: 104
USD 3950.00 (Single User License)
Global Drug Modeling Softwares Market Research Report 2024
Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
Published: 2024-02-06
Pages: 86
USD 2900.00 (Single User License)